Karyopharm is expected to present data from its Phase I study testing lead SINE program KPT-330 in solid tumors at the upcoming American Society of Clinical Oncology meeting in Chicago

Gilead Science Inc.'s oral targeted cancer drug, idelalisib (GS-1101), made a splash last week when the American Society of Clinical Oncology (ASCO) unveiled thousands of abstracts scheduled for presentation at next week's annual meeting in Chicago

Oncothyreon Inc.'s detailed results for its cancer immunotherapy product L-BLP25 (formerly Stimuvax), reported at the meeting of the American Society of Clinical Oncology Annual Meeting in Chicago, failed to comfort nervous investors

Additional edata will be presented at the annual meeting of the American Society of Clinical Oncology in Chicago

MedImmune's IMTC portfolio is "going to be the buzz" at the American Society of Clinical Oncology (ASCO) meeting that begins at the end of this month in Chicago, Bradley told BioWorld Today

The American Society of Clinical Oncology (ASCO) released the first of more than 4,700 abstracts late Wednesday in anticipation of its 2013 annual meeting, scheduled to attract more than 30,000 participants to Chicago from May 31 to June 4

Results of the trial will be presented at the annual meeting of the American Society for Clinical Oncology next month

the American Society of Clinical Oncology (ASCO) meeting

The trial, which will enroll 300 patients, is based on results from a Phase IIb study in newly diagnosed AML patients, 60-75, presented at the American Society of Clinical Oncology conference in 2011

Amgen said Phase III data of talimogene laherparepvec, or T-VEC, in melanoma will be presented at the American Society of Clinical Oncology 2013 Annual Meeting in June, and the primary analysis of the overall survival secondary endpoint is expected later this year

No more than 1.5 percent of global trials are conducted in India, according to the Indian Society for Clinical Research, but this number could begin to grow at a fast pace as biosimilars hit their stride

No more than 1.5 percent of global trials are conducted in India, according to the Indian Society for Clinical Research, but this number could begin to grow at a fast pace as biosimilars hit their stride

Final data have been submitted for presentation at American Society of Clinical Oncology meeting, which this year runs from May 31 through June 4 in Chicago

Final data have been submitted for presentation at American Society of Clinical Oncology meeting, which this year runs from May 31 through June 4 in Chicago

Final data have been submitted for presentation at American Society of Clinical Oncology meeting, which this year runs from May 31 through June 4 in Chicago

Rockland, Mass.-based EMD Serono, a subsidiary of Merck KGaA, of Darmstadt, Germany, plans to submit detailed trial results for presentation at the American Society of Clinical Oncology (ASCO) 2013 annual meeting in Chicago and for publication in a peer-reviewed journal

Findings with the recommended Phase II dosing schedule were reported at the American Society of Clinical Oncology annual meeting in June 2012

Dendreon Corp., of Bridgewater, N.J., reported findings from several ongoing or completed studies of Provenge (sipuleucel-T) in advanced prostate cancer ahead of the 2013 American Society of Clinical Oncology Genitourinary Cancers Symposium in Orlando, Fla

The data, from the latest pre-specified interim analysis of the study, were presented at the annual American Society of Clinical Oncology Genitourinary Cancers Symposium in Orlando, Fla